Globus Medical (GMED) PT Lowered to $77 at BTIG
BTIG analyst Ryan Zimmerman lowered the price target on Globus Medical (NYSE: GMED) to $77.00 (from $88.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
